Barclays Maintains Equal-Weight on Bausch Health Companies, Raises Price Target to $9
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and raises the price target from $7 to $9.
Barclays analyst Glen Santangelo maintains Bausch Health Companies (NYSE:BHC) with a Equal-Weight and raises the price target from $7 to $9.